Xiaoyun Zheng

Learn More
Systemic acquired resistance (SAR) is an important component of disease-resistance arsenal of plants, and is associated with enhanced potency of activating local and systemic defense-related responses upon pathogen attack. In this report, we demonstrated that pre-treatment with beta-aminobutyric acid (BABA), a new elicitor of SAR in the plants, enhanced(More)
Using advantages of priori Bayesian method, a reliability verification test method based on Hybrid Bayesian Prior Distribution was brought forward. The prior distribution of unknown parameters can be obtained by using conjugate prior distribution method. Prior moment method and Maximum entropy method were used respectively to calculate two different groups(More)
Of the plethora of studies that discuss requirements for successful irrigation management, few pay close attention to what actually happens when the supply of water becomes extremely low. Such an oversight in the literature is unfortunate, because this is precisely when management matters. To understand what separates success from failure in irrigation(More)
The aim of the study was to determine the clinical significance of EBV DNA in the peripheral blood mononuclear cells (PBMCs) from the patients with non-Hodgkin lymphoma (NHL). Newly diagnosed patients with NHL were enrolled in the study (n = 328), and clinical data retrospectively analyzed. EBV DNA was detectable in 34.8% of patients, and the positivity(More)
The prognosis of elderly patients with acute myeloid leukemia (AML) is poor, and the recommendation of standard-dose or low-intensity induction regimen for these patients remains controversial. We retrospectively analyzed treatment outcome and prognostic factors of elderly AML patients who had received either standard-dose or low-intensity induction(More)
Haplo-HSCT has been used when HLA-matched siblings are not available. Conditioning regimens aim to reduce tumor burden prior to HSCT and provide sufficient immunoablation. We report the outcome of haplo-HSCT in 63 consecutive patients from 2/2013 to 12/2015 (19 females/44 males) with high-risk or relapsed/refractory hematological malignancies (n=29-AML;(More)
  • 1